Dr. Reddy’s initiates process with DCGI for emergency use of Sputnik V by Drug Controller of India

Emergency use of Sputnik V sought, Dr. Reddy’s laboratories have initiated the process with DCGI for the emergency use authorisation of the vector-based platform vaccine candidates for Sputnik V. Dr. Reddy’s have been working in collaboration with Russian direct investment fund and they have been holding small clinical trials in India. They have stated that by the beginning of March, they will be seeking an emergency use approval by the Drug Controller

Dr. Reddy initiates the process with DCGI for emergency use of Sputnik V by Drug Controller of India. They have officially submitted all the papers and how the situation goes ahead is something to watch out for. Watch the video to know more!